Calumet Specialty Products
CLMT
113 hedge funds and large institutions have $286M invested in Calumet Specialty Products in 2015 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 33 reducing their positions, and 16 closing their positions.
113% more call options, than puts
Call options by funds: $15.6M | Put options by funds: $7.33M
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
21% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 33
12% more capital invested
Capital invested by funds: $256M → $286M (+$30M)
3% less funds holding
Funds holding: 117 → 113 (-4)
19% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 16
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$8.3M |
| 2 |
Stifel Financial
St. Louis,
Missouri
|
+$6.89M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$4.06M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$3.17M |
| 5 |
JP Morgan Chase
New York
|
+$3.1M |
Top Sellers
| 1 |
Barclays
London,
United Kingdom
|
-$17.8M |
| 2 |
SCA
Salient Capital Advisors
Houston,
Texas
|
-$3.07M |
| 3 |
CCM
Coe Capital Management
Highland Park,
Illinois
|
-$2.5M |
| 4 |
Renaissance Technologies
New York
|
-$2.33M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.32M |
CLMT Hedge Fund Activity: Q2 2015 in Review
113 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Calumet Specialty Products (CLMT) for Q2 2015, worth a combined $286M — up 12% from $256M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of CLMT and 13 opened new positions — a net loss of 3 holders — while 33 trimmed existing stakes and 40 added.
The largest buyer was UBS Group, adding an estimated $8.3M. The largest seller was Barclays, cutting an estimated $17.8M.
- 113 institutional investors held Calumet Specialty Products (CLMT) as of Q2 2015, down from 117 in Q1 2015.
- Funds reported $286M of Calumet Specialty Products stock for Q2 2015, up 12% quarter-over-quarter.
- 13 funds opened new Calumet Specialty Products positions in Q2 2015 and 16 closed out, a net change of -3 holders.
- The largest Calumet Specialty Products buyer in Q2 2015 was UBS Group, an estimated $8.3M added.
- The largest Calumet Specialty Products seller in Q2 2015 was Barclays, an estimated $17.8M sold.
Based on aggregated 13F filings for Q2 2015.